People · Operator
Named in public records as an officer, director or promoter · active 2013–2025 · Biotechnology, Other Health Care, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Pathos AI, Inc. | — | Biotechnology | Series D+ | $365.0M | $2.4B | 2024 |
| Novascan Inc. | — | Other Health Care | Series A | $11.1M | $25.5M | 2022 |
| Pressure Hemp, Llc | — | Other | Seed | $4.0M | $47.4M | 2021 |
| Osteovantage, Inc. | — | Other | Pre-Seed | $125K | $2.9M | 2013 |
Amit Mehta at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Amit Mehta on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Calvin Goforth | 1 | 10 |
| Mohamad Makhzoumi | 1 | 10 |
| Eric Lefkofsky | 1 | 8 |
| Tyrell Rivers | 1 | 6 |
| Mark Kidd | 1 | 5 |
| Omid Moghadam | 1 | 5 |
| Charles Link | 1 | 3 |
| Robert Storey | 1 | 3 |
| Ryan Fukushima | 1 | 2 |
| Craig Davis | 1 | 2 |
| C. Richard Piazza | 1 | 2 |
| Maurcio Jaimerena | 1 | 1 |
| Alex Dolan | 1 | 1 |
| Andrew Heinlein | 1 | 1 |
| Eric Lefkofky | 1 | 1 |
| C. Richard Plazza | 1 | 1 |
| William Gregory | 1 | 1 |
| Parminder Gyani | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.